A Taiwanese Research Institute Is Seeking Collaboration for Developing Anti-Globo H ADC, an Oncology Product, Either Through Licensing, Contract Services or Co-development
A Taiwanese non-profit biomedical research institute is developing Anti-Globo H ADC for cancer treatment. The product is currently in the stage of pre-clinical. They are seeking partners for out-licensing, contract services, and co-development in related to the development of anti-Globo H ADC.